Stefan Agewall

Stefan Agewall is Visiting Professor of Cardiovascular Science focusing on the cardiac health consequences of climate change at the Department of Clinical Sciences, Danderyd Hospital at Karolinska Institutet, as of 1 November 2023. He is also Professor of Cardiology at Oslo University in Norway.

Before that, he held a position as Head of CCU at Karolinska University Hospital. He has published more than 400 Medline indexed articles and his H-index is 84. Agewall is Editor-in-Chief of European Heart Journal-Cardiovascular Pharmacotherapy (IF 7.1) and Senior Consulting Editor of European Heart Journal. 
Agewall has participated in several ESC Committees, such as ESC Publication Committee, the Committee for Practice Guidelines and the ESC Congress Program Committee. He has also been chairman of ESC Working Group on Cardiovascular Pharmacotherapy.
On Clarivates list of the most Cited Researchers in the world 2020. Agewall was member of the ESC board as a councilor between 2020-2022.
 

Stefan Agewall and his research group study how temperature and temperature changes affect the risk of myocardial infarction and how air pollution and drug treatment influence the disease risk in relation to temperature and temperature changes. To do this, they use data from SMHI (the Swedish Meteorological and Hydrological Institute) and the SWEDEHEART registry with close to 229, 000 patients. Rapid changes in temperature are expected to increase globally as a product of climate change. If it transpires that certain temperatures or changes in temperature increase the risk of heart attack, it will be possible to give patients better advice on how to act in such situations. If certain drugs also turn out to affect the risk, the drug regimens can be adjusted accordingly. On a societal level, it is also important to know whether and, if so, how air pollution affects cardiovascular disease.